Aberrant expression of TRIM-containing protein 44 (TRIM44) acts as a promoter in multiple cancers. Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (HEC). TRIM44 expression was significantly higher in HEC tissues than corresponding normal tissues at both the mRNA (2.42 ± 0.52 vs 0.99 ± 0.25) and protein (1.01 ± 0.27 vs 0.30 ± 0.13) levels. Patients with high TRIM44 expression showed poor differentiation (P = 1.39 × 10 −5 ), advanced TNM stage (P = 3.87 × 10 −4 ) and, most importantly, significantly poorer prognosis (P = 2.80 × 10 −5 ). TRIM44 played a crucial role in epithelial mesenchymal transition (EMT). A significant correlation was observed between TRIM44 and Ki67 expression. We demonstrated that TRIM44 markedly enhanced HEC cell proliferation, migration, and invasion. Additionally, TRIM44 was involved in the AKT/mTOR signaling pathway and its downstream targets, such as STAT3 phosphorylation.
mouse brain cDNA library. 8, 9 Accumulating data suggest that TRIM44 plays stimulatory and cancerogenic roles in multiple cancers. TRIM44 overexpression facilitates cell proliferation, migration, and invasion in gastric cancer, 10 hepatocellular carcinoma, 11 testicular germ cell tumors, 12 and non-small cell lung cancer (NSCLC). 13, 14 In addition, knocking down endogenous TRIM44 expression inhibits proliferation and motility in cancer cells. [10] [11] [12] [13] Moreover, TRIM44 has been identified as an independent prognostic marker in patients with different types of cancer. 10, 11, 14 Mechanistically, TRIM44 functions as a vital regulator of carcinogenesis through different downstream signaling pathways. For example, TRIM44 promotes non-small cell lung cancer via the mammalian target of rapamycin (mTOR) and nuclear factor (NF)-κB signaling pathways. 13, 14 In 2010, FITZGERALD, on behalf of the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group 15 revealed the prognostic value of TRIM44 in adenocarcinoma of the esophageal junction and gastric cardia.
In 2014, these authors also demonstrated that TRIM44 can serve as a potential therapeutic marker for relevant cancers. 16 However, the function and mechanism of TRIM44 in other types of esophageal cancer remain largely unknown. Considering the similarities in cancer pathogenesis between esophageal and gastric cancer, 17 we investigated the clinical and molecular mechanisms of TRIM44 in HEC.
In the present study, we explored the altered expression of TRIM44 in HEC and examined its relationship with clinicopathological characteristics and biological function. Finally, we determined the molecular mechanisms of TRIM44 in HEC progression.
| MATERIALS AND METHODS

| HEC tissue samples
A total of 100 pairs of esophageal tissue samples were randomly collected from HEC patients who underwent curative resection from January 2005 to January 2006 at the Second Affiliated Hospital of Nanchang University (Nanchang, China) and the Affiliated Hospital of Hainan Medical University (Haikou, China). The distances between the corresponding adjacent normal tissues and HEC lesions were at least 3-4 cm. Detailed clinical data and information on the storage of the specimens were previously described. 18 Informed consent was obtained from all patients. Ethics approval was given by the Research Ethics Committees of the Second Affiliated Hospital of Nanchang University and the Affiliated Hospital of Hainan Medical University.
| Cell lines
The human normal esophageal epithelial cell line HEEC and esophageal squamous cell carcinoma cell lines, including KYSE150, EC109
and KYSE510, were obtained from the American Type Culture Collection and maintained in our laboratory. The human esophageal squamous cell carcinoma cell lines KYSE140 and EC9706 were purchased from the Chinese Academy of Sciences. Cell lines including ECA109, HEEC and KYSE510 were maintained in Dulbecco's modified Eagle's medium (DMEM) (HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (Gibco, Waltham, MA, USA), streptomycin sulfate (100 IU/mL) and penicillin (100 μg/mL).
KYSE150, KYSE140 and EC9706 cells were cultured in RPMI 1640
(HyClone) with the same supplements. All cell lines were incubated at 37°C in a humidified incubator with 5% CO 2 .
| Tissue microarray construction, immunohistochemistry and evaluation
The construction and detailed information on the tissue microarray (TMA) utilized in the present study have been previously described.
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Immunohistochemistry (IHC) was performed as described. 19, 20 Briefly, a total of 100 cases of HEC were included, and all samples were reviewed and confirmed via hematoxylin and eosin (H&E) staining. The slides were deparaffinized in xylene and rehydrated with alcohol. Diluted hydrogen peroxide (3%) was used to inactivate endogenous peroxidase activity, followed by washing with phosphate-buffered saline (PBS). After being blocked with 5% bovine serum albumin (BSA, YESEN, Shanghai, China), the sections were treated with primary rabbit antibodies against TRIM44
(11511-1-AP; 1:150 dilution; Proteintech, Chicago, IL, USA) and mouse antibodies against Ki67 (#9449; 1:400 dilution; Cell Signaling Technology, Beverly, MA, USA) and incubated overnight at 4°C.
The next day, the sections were incubated for 1 hour with horseradish peroxidase (HRP)-labeled secondary antibody (Gene Tech; Shanghai, China) and then stained using diaminobenzidine (DAB, Gene Tech). Finally, the slides were imaged on a microscope (Olympus, Tokyo, Japan) with the same settings.
TRIM44 staining was evaluated based on intensity scores (0, no staining; 1, weak staining; 2, moderate staining; and 3±, strong staining) and percentage scores (0, 0%; 1 ≤25%; 2, >25%-≤50%; 3, 50%-≤75%; 4, >75%). Final scores were evaluated using a combination of intensity and percentage scores: scores ≤3 were defined as the low expression group and those ≥4 were considered the high expression group. 
| RNA isolation and quantitative real-time PCR
| Cell migration and Matrigel invasion assays
Migration and invasion assays were performed using Transwell chambers with an 8-μm pore size (24-well format, Corning, Corning, NY, USA). For invasion assays, cells (1 × 10 5 ) suspended in serumfree medium were added to the upper chamber, which had been pre-coated with 50 μL of diluted Matrigel (1:6; BD Biosciences, San
Jose, CA, USA). DMEM or 1640 medium supplemented with 30%
FBS was added to the lower chambers, and the cells were cultured in a thermostatic incubator with 5% CO 2 at 37°C for 48 hours. For the migration assay, the cells were directly added to the upper chamber without diluted Matrigel and cultured under the same conditions. Finally, the cells that migrated to or invaded the underside of the Transwell chambers were stained with 0.5% crystal violet and counted on an inverted microscope.
| Lentivirus construction and transfection
pGMLV-SC5-shRNA-TRIM44 (shRNA: short hairpin RNA)-and PGMLV-PE3-TRIM44-expressing lentivirus carrying green fluorescent protein (GFP) and red fluorescent protein (RFP), respectively, were designed and provided by Genomeditech (Shanghai, China). The target shRNA sequences are shown in Table S1 . KYSE510 and The TRIM44-overexpression cell line was named KYSE140-oe, and KYSE140-nc was used as a control.
| Immunofluorescence
For immunofluorescence assays, stably transfected cells were fixed according to the Kaplan-Meier method (log-rank test used to test for differences between different groups). A Cox proportional hazards model, which was used for univariate and multivariate analyses, was applied to identify important prognostic factors for overall survival (OS). All P values were two-sided, and P < .05 was considered statistically significant.
| RESULTS
| TRIM44 is overexpressed in HEC
To elucidate the potential role of TRIM44 in cancer, we used Oncomine (a publicly available data source) to investigate TRIM44 mRNA expression in cancer samples. Representative results suggested that TRIM44 mRNA levels were frequently elevated in colorectal carcinoma 21 and gastric cancer 22 ( Figure 1A,B) . Elevated TRIM44 expression is therefore related to multiple human cancers.
We next examined TRIM44 expression in HEC using quantitative The results also demonstrated that TRIM44 protein levels were indeed increased in HEC tissues ( Figure 1D ; 1.01 ± 0.27 vs 0.30 ± 0.13). These results revealed that TRIM44 mRNA and protein levels are frequently elevated in HEC.
| TRIM44 overexpression is associated with aggressive phenotypes and poor prognosis in HEC patients
We then focused on the clinical characteristics of TRIM44 expression in HEC patients. The expression of TRIM44 varies greatly in HEC tissues (Figure 2A ). Based on the TRIM44 immunostaining intensity and percentage scores mentioned above, the cohort of 100
HEC patients was divided into TRIM44 high and TRIM44 low groups.
We found that elevated TRIM44 expression was more frequently detected in HEC tissues than in corresponding non-tumorous tissues in this cohort of patients ( Figure 2B ). As shown in Table 1 Figure 2E ). In addition, patients with a higher TNM stage and poorer differentiation had a more unfavorable OS (Figure 2D,F) .
We next observed the prognostic value of TRIM44 using an online tool (http://kmplot.com/analysis/). We found that gastric cancer patients with high TRIM44 expression exhibit unfavorable OS (Figure 2G) . Consistent with the kmplot analysis data in gastric cancer, patients in the high TRIM44 expression group had obviously worse OS than those in the low TRIM44 expression group (26.4% vs 68%,
, Figure 2H ). Univariate analysis revealed that poor F I G U R E 1 Increased TRIM44 expression levels in different types of cancer and prediction of an unfavorable outcome (data retrieved from Oncomine and Kaplan-Meier Plotter). A, TRIM44 transcript levels in gastric mucosa and gastric cancer vs gastric tissues (P = .002, fold change = 1.633); B, TRIM44 transcript levels in colorectal carcinoma vs colon tissues (P = 5.01E-11, fold change = 1.725); C, relative TRIM44 mRNA expression in 15 paired human esophageal cancer (HEC) tissues (T) and adjacent non-tumor tissues (N) (P < .01); D, relative TRIM44 protein levels in 8 paired HEC tissues (T) and adjacent non-tumor tissues (N) (P < .01). (T: tumor, N: peritumor; *P < .05, **P < .01, and ***P < .001) : low expression of TRIM44; *P < .05, **P < .01, and ***P < .001) independent prognostic factor for OS. Taken together, these data predicted that TRIM44 overexpression indicated significantly worse prognosis in HEC patients (Table 2 ).
| TRIM44 induces cell migratory and invasive abilities in HEC cell lines by regulating epithelialmesenchymal transition (EMT)
The clinical characteristics and prognostic value of TRIM44 in HEC prompted us to further examine its potential biological functions.
Constitutive expression of TRIM44 in 5 HEC cell lines, as well as the normal esophageal epithelial cell HEEC, was confirmed ( Figure 3A ).
We stably down-regulated TRIM44 in KYSE510 cells with high TRIM44 expression ( Figure 3B ). We also successfully overexpressed the TRIM44 gene in KYSE140 cells with low TRIM44 expression ( Figure 3C ). The different levels of TRIM44 were confirmed via western blotting.
Published studies have also reported that increased TRIM44 expression promoted cell migration and invasion in NSCLC and hepatocellular carcinoma by regulating key components of EMT. 11, 13 We therefore investigated whether TRIM44 similarly mediated EMT to promote cell migration and invasion in HEC cell lines. Transwell migration and invasion assays, as well as wound-healing assays, were used to determine the effects of TRIM44 on migration and invasion in both Increased E-cadherin and down-regulated N-cadherin and Vimentin expression were observed in TRIM44-overexpressing HEC cells (Figure 4B,D) . We also investigated the function of TRIM44 in other cells (EC9706 and KYSE150) by overexpressing TRIM44 or knocking down TRIM44 ( Figure S1 ). Together, these observations suggest that TRIM44 promotes HEC cell migration and invasion by regulating EMT.
High TRIM44 expression was associated with impaired E-cadherin expression and high levels of Vimentin. However, low TRIM44 expression was associated with increased E-cadherin expression and low levels of Vimentin; representative images are shown in Figure 4E . A significant negative association was observed between TRIM44 and Ecadherin expression in this cohort of patients (R 2 = 0.5072 and P < .001; Figure 4F ), and the TRIM44 expression was positively correlated with Vimentin (R 2 = 0.4904 and P < .001; Figure 4F ).
| TRIM44 modulates Ki67 expression and promotes HEC cell proliferation
CCK8 and colony formation assays were performed to determine the role of TRIM44 in HEC cell proliferation. The CCK8 assays indicated that compared with the control cells, TRIM44-overexpressing HEC cells exhibited significantly increased proliferation, whereas significantly decreased proliferation was observed in HEC cells with with Ki67. 11 Considering the strict association between cell proliferation and Ki67, 24 we next examined the correlation between Ki67 and TRIM44 in HEC. We randomly selected 8 pairs of fresh HEC specimens for IHC analysis to assess the connection between TRIM44 and Ki67. Figure 5C is a representative picture of the results. Immunohistochemical staining of TRIM44 was similar to Ki67 staining (Figure 5C ). In addition, TRIM44-positive expression was more frequently detected in HEC tissues than in non-tumorous tissues ( Figure 5C ).
Immunofluorescence assays showed that TRIM44-overexpressing KYSE140 cells exhibited significant up-regulation of Ki67, whereas TRIM44-silenced KYSE150 cells showed a loss of Ki67 ( Figure 5D ).
| High levels of TRIM44 induce HEC cell EMT
by the PI3K pathway w?>Previous studies have revealed that TRIM44 is highly associated with the PI3K pathway in esophagogastric cancer (EGC) 25 and NSCLC. 13 Here, we also showed that shRNA knockdown of TRIM44 in KYSE510 cells caused a decrease in p-AKT (Ser473) levels, as well as weak p-mTOR activity. In contrast, TRIM44 overexpression in KYSE140 cells led to increased p-AKT (Ser473) and p-mTOR activity ( Figure 6A ). Interestingly, the phosphorylation levels of STAT3, which represents a point of convergence for numerous oncogenic pathways, [25] [26] [27] were markedly enhanced in KYSE140-oe cells and down- 
| DISCUSSION
In the present study, we reported that TRIM44 was commonly amplified in HEC specimens compared with its expression in corresponding normal tissues, consistent with the Oncomine analysis of prostate cancer, colorectal carcinoma 21 and gastric cancer. 22 Patients with TRIM44 overexpression showed poor differentiation, OS, overall survival; 95% CI, 95% confidence interval; multivariate analysis, Cox proportional hazards regression model. Variables were adopted for their prognostic significance by univariate analysis with forward stepwise selection (forward, likelihood ratio). Variables were adopted for their prognostic significance by univariate analysis (P < .05).
F I G U R E 3 Overexpression of TRIM44 accelerates human esophageal cancer (HEC) cell migration and invasion. A, Relative TRIIM44 protein levels in HEC cell lines. Glyceraldehyde-3-phosphate dehydrogenase (GADPH) was used as a loading control; B,C, efficiency of TRIM44 overexpression and down-regulation in HEC cells; D,E, Transwell assays were used to measure the effects of TRIM44 overexpression and down-regulation on migration and invasion; F,G, wound-healing assays were used to evaluate the migration of KYSE510 and KYSE140 cells. (*P < .05, **P < .01, and ***P < .001)
advanced TNM stage and, most importantly, significantly poorer prognosis. TRIM44 down-regulation suppressed HEC cell proliferation, migration and invasion. In contrast, overexpressing TRIM44 in HEC cells promoted these activities. We also observed that TRIM44 played a crucial role in EMT. TRIM44 staining was similar to that of Ki67 by IHC. Additionally, overexpressing or knocking down TRIM44 successfully reduced or enhanced Ki67 expression, respectively, in immunofluorescence assays. These results revealed a significant association between TRIM44 and the AKT/mTOR signaling pathway. Collectively, our preliminary study strongly F I G U R E 4 TRIM44 promotes human esophageal cancer (HEC) cell migration and invasion by promoting epithelial mesenchymal transition (EMT) and histopathological correlation of TRIM44 expression and EMT phenotypes in the tissue. A,B, Effects of TRIM44 overexpression and down-regulation on epithelial and mesenchymal makers (including E-cadherin, Vimentin and N-cadherin) using fluorescence staining; C,D, changes in key molecules of EMT determined by western blot analyses after overexpression and down-regulation of TRIM44 in KYSE140 and KYSE510 cells, respectively. E, High TRIM44 expression was associated with impaired E-cadherin expression and high levels of Vimentin. Low TRIM44 expression was associated with increased E-cadherin expression and low levels of Vimentin. F, The correction between TRIM44 and E-cadherin expression according to the integrated optical density of the immunostaining. B, The correction between TRIM44 and Vimentin expression according to the integrated optical density of the immunostaining F I G U R E 5 TRIM44 modulates Ki67 expression and promotes human esophageal cancer (HEC) cell proliferation. A,B, Cell Counting Kit-8 (CCK8) and colony formation assays were used to detect cell proliferation in TRIM44 overexpression and down-regulation of HEC cells; C, representative images of TRIM44 and Ki67 protein expression in the same tissues; D, representative fluorescence staining pictures of Ki67 expression changes induced by TRIM44 overexpression and down-regulation in HEC cells. (*P < .05, **P < .01, and ***P < .001)
suggests that TRIM44 overexpression may represent an important factor in HEC progression and a be candidate prognostic marker.
Epithelial mesenchymal transition, which is characterized by the loss of cell-cell adhesion and increased cell motility and invasion, is a major process underlying tumor metastasis. 23, 28 Previous studies have reported that TRIM44 promotes NSCLC cell invasion and metastasis by inducing EMT. 14 To this end, we evaluated changes in key components of EMT in both TRIM44-overexpressing and F I G U R E 6 Association between TRIM44 overexpression and PI3K signaling activity. A, Western blot detection of p-AKT, AKT, p-mTOR, p-STAT3 and STAT3 in KYSE510-nc and KYSE510-sh cell lines. B, Western blot detection of p-AKT, AKT, p-mTOR, p-STAT3 and STAT3 in KYSE140-nc and KYSE140-oe cell lines. C, Transwell assays were performed to investigate changes in KYSE140-oe cells after treatment with hydrochloride (A-674563, an AKT inhibitor). D,F, Proliferation of KYSE140-nc and KYSE140-oe cells was measured by CCK8 and colony formation assays after treatment with hydrochloride. E, Western blots analyzed molecules of the PI3K pathway and epithelial mesenchymal transition markers in KYSE140-nc and -oe cells treated by hydrochloride or phosphate-buffered saline. (*P < .05, **P < .01, and ***P < .001) TRIM44-silenced HEC cells. TRIM44 expression was positively associated with N-cadherin and Vimentin, whereas TRIM44 and E-cadherin expression levels were inversely correlated. Thus, TRIM44 may regulate HEC cell migration and invasion by activating EMT. However, the precise mechanism underlying TRIM44-mediated EMT in HEC remains unknown and requires further exploration.
Accumulating evidence indicates that the activation of the AKT/ mTOR pathway plays a key role in controlling fundamental cellular processes, including cell growth, proliferation, apoptosis and metabolism in different cancer types. 29, 30 A previous study showed a statistically significant correlation between TRIM44 and the mTOR signaling pathway in EGC. 31 The TRIM44-overexpression gene signature of EGC was reversed by AKT/mTOR pathway inhibitors. 31 Similarly, TRIM44 overexpression resulted in high mTOR activity in NSCLC. 13 In light of these previous reports, we examined the relationship between TRIM44 and the AKT/mTOR signaling pathway in HEC. We observed significant alterations in the phosphorylation levels of AKT/ mTOR signaling pathway molecules after TRIM44 up-regulation or knockdown. Interestingly, STAT3 phosphorylation levels were also affected. In addition, the phosphorylation levels of AKT/mTOR signaling pathway members and its downstream targets were re-inhibited by AKT inhibitors. STAT3 is constitutively activated in multiple cancers, such as breast, lung, colorectal and prostate cancers. 26, 32, 33 Moreover, STAT3 is a point of convergence for many oncogenic pathways, including AKT/mTOR, that are involved in cell proliferation, apoptosis, cell proliferation, migration, survival and tumorigenesis. 34 However, the mechanism by which TRIM44 regulates the AKT/mTOR signaling pathway in HEC remains to be determined.
Our results demonstrate that TRIM44 promotes HEC cell proliferation, migration and invasion. TRIM44 might function by modulating the AKT/mTOR signaling pathway and contributing to EMT.
Moreover, TRIM44 expression may serve as a promising prognostic indicator and a potential therapeutic target for HEC patients.
